SEC Form 4 · accession 0000899243-15-004675
IMMUNIC, INC. · IMUX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean Jacques Bienaime
Director
Period of report
Sep 9, 2015
Accepted (ET)
Sep 11, 2015 · 12:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280776
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 9, 2015 | P | 4,000 | $3.07 | A | 29,119 | D | |
| Common Stock | Sep 9, 2015 | P | 2,000 | $3.10 | A | 31,119 | D | |
| Common Stock | Sep 9, 2015 | P | 2,000 | $3.16 | A | 33,119 | D | |
| Common StockF1 | Sep 10, 2015 | P | 6,000 | $3.0489 | A | 39,119 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average share price of an aggregate total of 6,000 shares purchased in the price range of $3.04 to $3.0599 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.